Development of novel "patient-tailored DDS"by plasma technique
Development of novel "patient-tailored DDS"by plasma technique
批准号:
14370730
负责人:
KUZUYA Masayuki
金额:
$8.26万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Although oral delivery is convenient to administration and acceptable for patients, the therapeutic effects often depend on the each patient's gastrointenstinal (GI) environment. Therefore, the "Patient-Tailored Drug Delivery System (DDS)" should be developed and administered based on the diagnosis of each patient's GI environment. We have studied plasma-assisted preparation of time-controlled DDS and intragastric floating DDS (FDDS) leading to the "Patient-Tailored DDS" targeting the GI tract. Double-compressed tablets composed of drug tablet as a core material and polymer powder, which was used as pharmaceutical aids, as a wall material was prepared to fabricate time-controlled DDS and inttragastric FDDS.Since plasma-crosslinkable acrylic monomers are one of the component polymers in Eudragits L100-55, argon plasma-irradiation would lead to the suppression of Eudragit L100-55 solubility even in a dissoluble pH-value solution due to the occurrence of the surface cross-link reactions. … More When Eudragit L100-55 is used as a wall material of the double-compressed tablet, the initial drug release could be completely sustained for a certain period of time. The lag-time could be controlled by plasma operational conditions.We have obtained the intragastric FDDS by plasma-irradiation when the double-compressed tablet was prepared using the outer layer to trap evolved carbon dioxide. The double-compressed tablet was prepared using methyl vinyl ether-maleic anhydride copolymer (VEMA), and a mixture of VEMA and hydroxypropyl methylcellulose phthalate as an outer layer. It was found that the tablet plasma-irradiated remains buoyant in the simulated gastric fluids for a prolonged period of time, and the drug release is considerably suppressed. The drug release can be controlled at a desired rate from the tablets by selecting the plasma operational tunings.The present results have clearly shown that one can prepare a variety of desired DDS devices, if one selects the tailored-polymers for wall materials of double-compressed tablets as well as plasma operational conditions. Less
期刊论文(80)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Development of Patient-Tailored Drug Delivery System by Plasma Techniques
利用等离子体技术开发患者定制的药物输送系统
DOI:
--
发表时间:
2004
期刊:
J.Photopolym.Sci.Technol. 17
影响因子:
--
作者:
[Y.Sasai, Y.Sakai, T.Nakagawa, S.Kondo, M.Kuzuya]
通讯作者:
M.Kuzuya
高分子材料のプラズマ表面処理
高分子材料的等离子表面处理
DOI:
--
发表时间:
2003
期刊:
ケミカルエンジニヤリング 48
影响因子:
--
作者:
[葛谷昌之]
通讯作者:
葛谷昌之
近藤伸一, 古田陽司, 大北信太郎, 笹井泰志, 荒巻秀樹, 葛谷昌之: "ステンレス製容器を用いたメカノケミカル固相反応によるリボフラビンラジカルの生成"薬学雑誌. 124. 141-148 (2004)
Shinichi Kondo、Yoji Furuta、Shintaro Ohkita、Yasushi Sasai、Hideki Aramaki、Masayuki Kuzuya:“使用不锈钢容器通过机械化学固相反应生成核黄素自由基”医药杂志 124. 141-148 (2004)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
葛谷昌之: "プラズマ法による薬物製剤化"化学と薬学の教室. 147. 27-32 (2002)
Masayuki Kuzutani:“使用等离子体方法的药物制剂”化学与药学系 147. 27-32 (2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
低温プラズマ技術によるDDSの薬物放出制御の設計と開発に関する研究
利用低温等离子体技术的DDS控释药物设计与开发研究
DOI:
--
发表时间:
2003
期刊:
岐阜薬科大学紀要 52
影响因子:
--
作者:
[伊藤幸祐, 葛谷昌之]
通讯作者:
葛谷昌之
共 33 条
Development of Novel Drug Engineering Utilizing the Electronic Property on the Solid Surface
-
批准号:11672147
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:KUZUYA Masayuki
-
依托单位:
Development of new functionalized composite powders using plasma chemistry and its applications to drug engineering
-
批准号:09672191
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:1997
-
负责人:KUZUYA Masayuki
-
依托单位:
A New Drug Delivery System (DDS) Developement Using Plasma-Irradiated Pharmaceutical Aids
-
批准号:04671327
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.28万
-
财政年份:1992
-
负责人:KUZUYA Masayuki
-
依托单位: